Epigenomics AG (Frankfurt:ECX) (Prime Standard:ECX), a molecular diagnostics company developing tests based on DNA methylation, today reported its financial results for the fiscal year ending December 31, 2005.
Epigenomics AG (Frankfurt:ECX) (Prime Standard:ECX), a molecular diagnostics company developing tests based on DNA methylation, today reported its financial results for the fiscal year ending December 31, 2005.